Introduction: The Critical Role of Filgrastim in Global Healthcare and Why a Buyers List Matters Filgrastim, a recombinant granulocyte-colony stimulating factor (G-CSF) medication, is a cornerstone of modern oncology and hematology care. It stimulates the production of white blood cells, reducing the risk of infection in patients undergoing chemotherapy, radiation therapy, or stem cell transplants. As global cancer rates rise—with the WHO projecting a 50% increase in new cases by 2040—demand for filgrastim continues to grow, creating opportunities for manufacturers, distributors, and suppliers. For businesses in the pharmaceutical supply chain, accessing a reliable Filgrastim Global Buyers List is pivotal. This list identifies key entities purchasing filgrastim, from large hospital networks…